​Early diagnostic intervention and an accurate understanding of disease etiology remain vital pillars in lowering the global burden of lung cancer. While traditional medical research funding often flows toward large-scale clinical trials or therapeutic drug development, early-stage investigations require distinct, focused capital. To address this specific gap, Lung Cancer Canada (LCC) administers the Geoffrey Ogram Memorial Research Grant (GOMRG).
​This grant program was established in honor of Geoffrey Ogram, a dedicated physicist, former board member, and co-chair of Lung Cancer Canada’s Advocacy Committee who passed away from the disease in 2016. The grant is designed to catalyze innovation by funding projects along the entire research spectrum—from basic discovery to translational science with distinct clinical relevance. It targets the initial phases of research, giving investigators the baseline funding required to test unproven hypotheses and generate preliminary data.
​Quick Summary Box
| Key Feature | Details |
|---|---|
| Opportunity Name | Geoffrey Ogram Memorial Research Grant (GOMRG) |
| Grantor Agency | Lung Cancer Canada (LCC) |
| Total Available Awards | Up to two (2) grants per cycle |
| Value Per Award | $25,000 CAD |
| Funding Duration | Up to one (1) year |
| Primary Focus Areas | Early detection and lung cancer etiology across diverse demographics |
| Application Deadline | September 30, 2026, at 11:59 PM PST |
Opportunity Overview
​The GOMRG aims to reduce the burden of lung cancer by supporting researchers who are developing new knowledge with the potential to improve patient care.
​Proposals submitted to this program must fall within two main research directions: the early detection of lung cancer or the study of lung cancer etiology. The adjudication committee favors projects that deliver practical, scalable, and translational outcomes of direct relevance to Canadians navigating a lung cancer diagnosis.
​Benefits
​Recipients of the Geoffrey Ogram Memorial Research Grant obtain key institutional and financial advantages:
- ​Direct Project Funding: An allocation of $25,000 CAD covers the tangible, immediate costs of running a focused study.
- ​Proof-of-Concept Validation: The grant acts as seed funding, helping researchers build a foundational dataset necessary to apply for larger national or international grants (such as CIHR or NIH awards).
- ​Professional Recognition: Winning a competitive award from a national organization like Lung Cancer Canada increases the visibility of the investigator’s research program.
- ​Freedom of Scope: Funding spans across multiple scientific domains, accepting applications from biomedical, clinical, health services, social, and population health research.
​Eligibility Criteria
​The GOMRG utilizes a structured definition of eligible applicants to ensure institutional accountability and scientific independence.
- ​Autonomous Status: Applicants must meet the criteria of an independent researcher who maintains full autonomy regarding their scientific activities.
- ​Academic Appointment: The principal investigator must hold a formal academic or research appointment at an eligible Canadian institution (universities, affiliated hospitals, or research institutes) that is active by the effective start date of the funding.
- ​Supervisory Capability: The individual’s appointment must officially allow them to pursue independent research, supervise trainees (where applicable under institutional policy), and publish their scientific findings.
- ​Institutional Compliance: The applicant must be obligated to conform to their host institution’s internal regulations regarding research conduct and staff employment conditions.
​Eligible Healthcare Professions
​The GOMRG encourages applications from multidisciplinary teams operating within oncology and public health.
| Profession / Field | Role in Grant Projects |
|---|---|
| Oncologists & Pulmonologists | Leading clinical and translational research directly connected to patient pathways. |
| Epidemiologists | Analyzing demographic patterns, environmental risk factors, and population datasets. |
| Pathologists & Radiologists | Developing and testing innovative screening tools, biomarkers, and imaging modalities. |
| Basic Scientists / Biologists | Investigating molecular pathways and disease mechanisms in laboratory environments. |
| Health Services Researchers | Evaluating diagnostic accessibility and optimizing clinical screening delivery models. |
IMG/International Applicant Considerations
​The Geoffrey Ogram Memorial Research Grant is restricted to research conducted within Canadian host institutions.Â
​Required Documents
​To complete the application package for Lung Cancer Canada's adjudication panel, candidates must compile and submit the following components:
- ​Letter of Intent (LOI): An introductory summary outlining the project's purpose and alignment with LCC goals.
- ​Summary of Proposed Research: A detailed scientific narrative explaining the methodology, objectives, and experimental design.
- ​Impact Statement: A clear explanation of how the project will accelerate early detection or improve the understanding of lung cancer etiology.
- ​Public Lay Summary: A non-technical description of the project written for patients, donors, and the general public.
- ​Justified Budget: An itemized spreadsheet detailing exactly how the $25,000 CAD will be utilized for direct research costs.
- ​Canadian Common CV (CCV): Updated academic and research histories for all Principal Investigators and Co-Investigators.
- ​Institutional Statement of Support: A signed endorsement from the host university or hospital confirming compliance and resource availability.
​Application Process
​The submission process flows through internal institutional screening before reaching Lung Cancer Canada:
- ​Draft Internal Records: Open a pre-award application within your institution's online system (e.g., RMS or RFAA tracking portals).
- ​Secure Institutional Approval: Submit documents to department heads or Faculty Associate Deans for internal validation, ensuring compliance with institutional deadlines (frequently 5–7 days before the external deadline).
- ​Package Compilation: Gather the signed institutional statement of support alongside the core application documents.
- ​Final Electronic Submission: Upload and send the entire application package to Lung Cancer Canada via the designated portal or submission email as detailed in the official application guidelines.
​Tips to Increase Your Chances
- ​Emphasize Non-Smoking and Demographics Risks: Given Geoffrey Ogram’s background as a non-smoker, proposals investigating etiology in non-smokers, light ex-smokers, or underrepresented populations receive high programmatic priority.
- ​Demonstrate Clear Financial Need: The adjudication committee explicitly prioritizes equitable resource distribution and evaluates the financial need of the project. Be transparent about why this specific funding is essential to make the project viable.
- ​Focus on Diagnostic Innovation: Design proposals around emerging screening methodologies, such as liquid biopsies, blood-based biomarkers, or novel early-detection technologies.
​Common Mistakes to Avoid
- ​Including Indirect Costs: Allocating any portion of the $25,000 CAD to institutional overhead or indirect administrative fees will result in immediate budget disqualification.
- ​Using Funds Solely for Fellow Salaries: While wages for research assistants or staff are permitted when justified by the scope of work, this is a research grant, not a personal fellowship. It cannot be used completely to fund a single trainee salary.
- ​Ignoring the Lay Summary: Review panels often include patient advocates. Writing a poor, overly technical lay summary can negatively impact your overall score.
​Application Timeline
| Phase | Recommended Completion Window |
|---|---|
| Phase 1: Project Alignment & Team Assembly | July to Early August |
| Phase 2: Narrative Drafting & Budget Itemization | Late August |
| Phase 3: Internal Institutional Review Submission | Mid-September (approx. Sept 24) |
| Phase 4: Final Adjustments & LCC Submission | Prior to September 30 |
Â
Deadline
​The official submission closing date for the 2026 funding cycle is September 30, 2026, at 11:59 PM PST. Because internal university or hospital research services offices (RSO) require time to sign off on applications, candidates should expect internal deadlines to fall around September 24, 2026.
​FAQs
​Q: Can the grant money be used to fund awareness or educational campaigns?
A: No. The GOMRG is a research grant and does not support public health awareness campaigns or public relations initiatives.
​Q: Is it permissible to purchase equipment with these funds?
A: Yes. Budgets may include specific equipment purchases, provided they are direct costs entirely associated with executing the proposed research project.
​Q: Can clinical trials be funded through this mechanism?
A: While translational and clinical research are eligible, the $25,000 CAD funding ceiling makes this grant ideal for pilot clinical studies, proof-of-concept assessments, or secondary analysis rather than full-scale clinical trials.
​Official Link(s)
​To download the application guidelines and official document forms, visit the program page:
​Final Thoughts
​The Geoffrey Ogram Memorial Research Grant provides early-stage investigators with the vital seed capital required to pioneer innovative screening and diagnostic methodologies. By targeting early detection and disease etiology, this grant plays a distinct role in accelerating clinical advancements and optimizing future lung cancer care across Canada.
Leave a Comments
Login to comment
No comments yet.